Blood Diseases Market Research Reports & Industry Analysis


Blood Diseases Industry Research & Market Reports

  • Global Autoimmune Hemolytic Anemia Therapeutics Market - 2020-2027

    ... antibodies that attack red blood cells in the body. This reduces the red blood cells counts, causing hemolytic anemia. AHA can result from medication or an underlying disease or can be idiopathic. The key types ... Read More

  • Aplastic Anemia - Pipeline Insight, 2021

    ... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Aplastic Anemia ... Read More

  • Hemophilia A - Pipeline Insight, 2021

    ... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Hemophilia A ... Read More

  • Specialty Drug Distribution Market Research Report by Indication (AIDS, Hemophilia, Multiple Sclerosis, Oncology, and Rheumatoid Arthritis), by Type (Full line Wholesalers and Specialty Distributors), by Distribution Type, by Distribution Channel - Global

    ... 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency ... Read More

  • Bloodstream Infection Testing

    ... projected to reach a revised size of US$1.4 Billion by 2027, growing at aCAGR of 5.8% over the period 2020-2027. Conventional Testing, one of the segments analyzed in the report, is projected to record 6.3% ... Read More

  • Hemophilia Drugs

    ... a revised size of US$16.7 Billion by 2027, growing at a CAGR of 4.7% over the analysis period 2020-2027. Hemophilia A Drugs, one of the segments analyzed in the report, is projected to record a ... Read More

  • Intravenous (IV) Iron Drugs

    ... year 2020, is projected to reach a revised size of US$2.6 Billion by 2027, growing at a CAGR of 6.1% over the analysis period 2020-2027. Ferric Carboxyl Maltose, one of the segments analyzed in the ... Read More

  • Thalassemia Treatment

    ... a revised size of US$1.5 Billion by 2027, growing at a CAGR of 6.5% over the analysis period 2020-2027. Blood Transfusion, one of the segments analyzed in the report, is projected to record a 6.4% ... Read More

  • Bleeding Disorders Treatment

    ... projected to reach a revised size of US$19.9 Billion by 2027, growing at a CAGR of 6.7% over the analysis period 2020-2027. Hemophilia A, one of the segments analyzed in the report, is projected to ... Read More

  • Hemoglobinopathy

    ... of US$823.4 Million by 2027, growing at a CAGR of 6.9% over the analysis period 2020-2027. Sickle Cell Disease, one of the segments analyzed in the report, is projected to record a 6.5% CAGR and ... Read More

  • Iron Deficiency Anemia Therapy

    ... year 2020, is projected to reach a revised size of US$4 Billion by 2027, growing at a CAGR of 6% over the analysis period 2020-2027. Oral Iron Therapy, one of the segments analyzed in the ... Read More

  • Desmopressin

    ... of US$1.4 Billion by 2027, growing at a CAGR of 5.4% over the analysis period 2020-2027. Injectable Solution, one of the segments analyzed in the report, is projected to record a 5.9% CAGR and reach ... Read More

  • Rare Hemophilia Factors

    ... projected to reach a revised size of US$350.8 Million by 2027, growing at a CAGR of 4.8% over the analysis period 2020-2027. Fresh Frozen Plasma, one of the segments analyzed in the report, is projected ... Read More

  • Plasma Fractionation

    ... a revised size of US$31.9 Billion by 2027, growing at a CAGR of 5.4% over the analysis period 2020-2027. Intravenous Immunoglobulins, one of the segments analyzed in the report, is projected to record a 5.8% ... Read More

  • Rare Hematology

    ... a revised size of US$18 Billion by 2027, growing at aCAGR of 4.8% over the period 2020-2027. Plasma Derived Factors, one of the segments analyzed in the report, is projected to record 4.9% CAGR and ... Read More

  • Hemophilia Gene Therapy

    ... projected to reach a revised size of US$15.8 Billion by 2027, growing at a CAGR of 3.8% over the analysis period 2020-2027. Hemophilia A, one of the segments analyzed in the report, is projected to ... Read More

  • Global Bleeding Disorders Drugs Market, By Drug Type (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants, Others), By Disease Type (Hemophilia A, Hemophilia B, Von

    ... Channel (Hospital Pharmacies, Retail Pharmacies, Online), By Gender (Male v/s Female), By End User (Hospitals, Hemophilia Treatment Centers, Research Institutes, Others), By Region, Competition Forecast & Opportunities, 2026 Global Bleeding Disorders Drugs Market is expected ... Read More

  • Anticoagulants

    ... of US$42.2 Billion by 2027, growing at a CAGR of 6.5% over the analysis period 2020-2027. NOACs, one of the segments analyzed in the report, is projected to record a 7.5% CAGR and reach US$17.4 ... Read More

  • Anemia Drugs

    ... a revised size of US$46.5 Billion by 2027, growing at a CAGR of 7.2% over the analysis period 2020-2027. Iron Deficiency Anemia, one of the segments analyzed in the report, is projected to record a ... Read More

  • Chronic Kidney Disease Anemia - Global Drug Forecast and Market Analysis to 2029

    ... (EPO) due to kidney damage. CKD anemia is highly prevalent among CKD patients and its prevalence increases as CKD progresses, affecting more than half of patients in stage V. Over the last 20 years, the ... Read More

  • Hemophilia B- Market Insight, Epidemiology and Market Forecast -2030

    ... United States, EU5 (Germany, France, Italy, Spain, and United Kingdom), and Japan. The Hemophilia B market report provides current treatment practices, emerging drugs, Hemophilia B market share of the individual therapies, current and forecasted Hemophilia ... Read More

  • Blood Plasma Products Market in India 2021

    ... and comprises more than 700 proteins and other substances. It is a major component used in the treatment of health problems such as haemophilia and autoimmune disorders. Improved diagnostic facilities and the prevalence of chronic ... Read More

  • Hemophilia B - Epidemiology Forecast to 2030

    ... Spain, and the United Kingdom), and Japan. Hemophilia B Understanding Hemophilia is defined as an inherited bleeding disorder in which the blood does not clot properly. This can lead to spontaneous bleeding as well as ... Read More

  • Global Fc Fusion Protein Market Insights, Forecast to 2027

    ... market size will reach US$ 54282 million by the end of 2027, growing at a CAGR of 10.72% during 2021-2027. Global Fc Fusion Protein Scope and Segment Fc Fusion Protein market is segmented by Type, ... Read More

  • Chronic Kidney Disease-Anemia - Epidemiology Forecast to 2029

    ... definition, anemia refers to an absolute reduction of the total number of circulating red blood cells (RBCs). In CKD-anemia, the production of erythropoietin decreases, which leads to low RBC count and hence causes anemia. Anemia ... Read More

< prev 1 3 4 5 6 7 8 9 10

Research Assistance

Join Alert Me Now!

Sign Up

Find out more on our blog